Monthly Archives: November 2006

FDA update Tamiflu (oseltamivir) label

Posted on November 14, 2006 by admin

Patients who take Tamiflu should be closely monitored for signs of abnormal behavior, health officials said Monday in announcing an updated label for the flu drug. The added precaution comes after reports of more than 100 new cases of delirium, … Continue reading →

Posted in FDA | Comments Off

Patient Reporting Poster

Posted on November 8, 2006 by admin

We have produced a poster for local pharmacies and GP surgeries to promote the patient reporting of adverse drug reactions. You can download a printable PDF version here. Patients can report adverse drug reactions at http://www.yellowcard.gov.uk

Posted in News, Patient reporting, Yellow Card Scheme | Comments Off

Lamotrigine and teratogenicity

Posted on November 8, 2006 by admin

The FDA recently issued important new information relating to the safety of lamotrigine in pregnancy: New information suggests that babies exposed to Lamictal during the first three months of pregnancy may have a higher chance of being born with a … Continue reading →

Posted in FDA, teratogenicity | Comments Off

NSAID and coxib Safety information

Posted on November 4, 2006 by admin

The Commission on Human Medicine (CHM) has produced a variety of information sources related to the increased risk of thrombotic events related to non-steroidal anti-inflammatory drugs (NSAIDs) and slective COX2 inhibitors (coxibs). Link to MHRA information. The European Medicine Evaluation … Continue reading →

Posted in EMEA, MHRA | Comments Off